Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cidara Therapeutics (CDTX)
NASDAQ:CDTX
Holding CDTX?
Track your performance easily
CDTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$10.01 - $24.40
Previous Close$11.72
Volume5.18K
Average Volume (3M)26.97K
Market Cap
$81.68M
Enterprise Value-$77.58M
Total Cash (Recent Filing)$164.37M
Total Debt (Recent Filing)$4.30M
Price to Earnings (P/E)―
Beta1.71
Next Earnings
Nov 07, 2024EPS Estimate
-$4.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-24.92
Shares Outstanding7,038,241
10 Day Avg. Volume16,675
30 Day Avg. Volume26,974
Standard Deviation0.23
R-Squared0.06
Alpha-0.00717
Financial Highlights & Ratios
Price to Book (P/B)0.63
Price to Sales (P/S)2.09
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-3.61
Enterprise Value/Gross Profit-17.90
Enterprise Value/Ebitda0.64
Forecast
1Y Price Target
$24.50Price Target Upside111.12% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Cidara Therapeutics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CDTX FAQ
What was Cidara Therapeutics’s price range in the past 12 months?
Cidara Therapeutics lowest stock price was $10.01 and its highest was $24.40 in the past 12 months.
What is Cidara Therapeutics’s market cap?
Currently, no data Available
When is Cidara Therapeutics’s upcoming earnings report date?
Cidara Therapeutics’s upcoming earnings report date is Nov 07, 2024 which is in 48 days.
How were Cidara Therapeutics’s earnings last quarter?
Cidara Therapeutics released its earnings results on Aug 13, 2024. The company reported -$19.99 earnings per share for the quarter, missing the consensus estimate of -$4.1 by -$15.89.
Is Cidara Therapeutics overvalued?
According to Wall Street analysts Cidara Therapeutics’s price is currently Undervalued.
Does Cidara Therapeutics pay dividends?
Cidara Therapeutics does not currently pay dividends.
What is Cidara Therapeutics’s EPS estimate?
Cidara Therapeutics’s EPS estimate is -$4.25.
How many shares outstanding does Cidara Therapeutics have?
Cidara Therapeutics has 7,038,241 shares outstanding.
What happened to Cidara Therapeutics’s price movement after its last earnings report?
Cidara Therapeutics reported an EPS of -$19.99 in its last earnings report, missing expectations of -$4.1. Following the earnings report the stock price went up 5.844%.
Which hedge fund is a major shareholder of Cidara Therapeutics?
Among the largest hedge funds holding Cidara Therapeutics’s share is Fisher Asset Management LLC. It holds Cidara Therapeutics’s shares valued at N/A.
---
Cidara Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$24.50 (111.12% Upside)
$24.50 (111.12% Upside)
Blogger Sentiment
Bullish
CDTX Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 825.0 Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 3.1%
Last 30 Days ▼ 3.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-44.19%
12-Months-Change
Fundamentals
Return on Equity
-161.69%
Trailing 12-Months
Asset Growth
154.99%
Trailing 12-Months
Company Description
Cidara Therapeutics
Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of novel anti-infectives. Its product pipeline includes Rezafungin and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.
---
CDTX Stock 12 Month Forecast
Average Price Target
$24.50
▲(111.12% Upside)
Technical Analysis
Best Analysts Covering CDTX
1 Year
1 Year Success Rate
9/23 ratings generated profit
1 Year Average Return
+8.67%
reiterated a buy rating 5 days ago
Copying Ed Arce's trades and holding each position for 1 Year would result in 39.13% of your transactions generating a profit, with an average return of +8.67% per trade.
---